Sector News

ConvaTec strengthens its board

August 15, 2017
Life sciences

ConvaTec Group has appointed Dr Regina Benjamin and Margaret Ewing as non-executive directors with immediate effect.

Benjamin was United States surgeon general from 2009 – 2013 and is currently a non-executive director of Diplomat Pharmacy, Kaiser Foundation Hospitals and Health Plan, and Ascension Hospital System. She is a former non-executive director of Alere.

From 1992-2004 she served on the board of the Medical Association of Alabama, and in 1995, became the first young physician to be elected to the American Medical Association Board of Trustees. In 2008, she chaired the Federation of State Medical Licensing Boards.

Benjamin is CEO and practising physician at the Bayou La Batre Rural Health Clinic in Alabama, which she founded in 1990 and holds an endowed chair in Public Health Sciences at Xavier University of Louisiana. She will immediately join the corporate responsibility committee.

Ewing is currently a trustee of the board and chairman of the finance and audit committee of Great Ormond Street Hospital Children’s Charity. She is also the independent external member of the audit committee of the Lawn Tennis Association.

Ewing was previously a non-executive director of Standard Chartered, Whitbread and the Confederation of British Industry and the independent external member of the audit committee of John Lewis Partnership.

She was a corporate finance partner of Deloitte LLP between 1987-1999, returning to Deloitte in 2007 as a senior partner and retiring from the firm in 2012.

During the period 2007-2012 Mrs Ewing was vice-chairman and a member of the firm’s executive committee and the board, senior partner of the London practice and latterly managing partner for public policy, quality and risk.

Ewing was group chief financial officer of Trinity Mirror from 2000-2002 and of BAA plc from 2002-2006. She was also a member of the financial reporting review panel between 2011-2014. She will immediately join the audit and risk committee and corporate responsibility committee.

It was previously announced that Dr Raj Shah would be leaving the board of ConvaTec on 8 September 2017 following the reduction by Nordic Capital of its shareholding in the company.

Dr Ros Rivaz, who was appointed a non-executive director of the company on 21 June , will immediately join the nominations and remuneration committees in place of Shah.

Chairman Sir Christopher Gent said: “I am delighted to announce two appointments of individuals who bring a wealth of experience and knowledge to the Board.

“Also with the appointments of Regina and Margaret, we have fulfilled our promise to shareholders that we would appoint a Board which would comprise a majority of independent Directors and which would reflect the requirements and advantages of gender diversity.

“We look forward to benefiting from their contribution to the future success of the Company.”

Source: StockMarketWire

comments closed

Related News

October 2, 2022

GSK names Julie Brown, a 25-year AstraZeneca veteran, its first woman CFO

Life sciences

Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.

October 2, 2022

Moderna creates new launch preparation role, poaches Novartis exec as manufacturing lead

Life sciences

Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.

October 2, 2022

Torrent Pharma to acquire Curatio for $245.16m

Life sciences

The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).